Gjerstorff MF - Search Results

1

Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy.

Gjerstorff MF, Johansen LE, Nielsen O, Kock K, Ditzel HJ. Gjerstorff MF, et al. Br J Cancer. 2006 Jun 19;94(12):1864-73. doi: 10.1038/sj.bjc.6603163. Br J Cancer. 2006. PMID: 16773077 Free PMC article.

2

Identification of genes with altered expression in medullary breast cancer vs. ductal breast cancer and normal breast epithelia.

Gjerstorff MF, Benoit VM, Laenkholm AV, Nielsen O, Johansen LE, Ditzel HJ. Gjerstorff MF, et al. Int J Oncol. 2006 Jun;28(6):1327-35. Int J Oncol. 2006. PMID: 16685433

3

MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development.

Gjerstorff MF, Kock K, Nielsen O, Ditzel HJ. Gjerstorff MF, et al. Hum Reprod. 2007 Apr;22(4):953-60. doi: 10.1093/humrep/del494. Epub 2007 Jan 5. Hum Reprod. 2007. PMID: 17208940

4

An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members.

Gjerstorff MF, Ditzel HJ. Gjerstorff MF, et al. Tissue Antigens. 2008 Mar;71(3):187-92. doi: 10.1111/j.1399-0039.2007.00997.x. Epub 2008 Jan 7. Tissue Antigens. 2008. PMID: 18179644 Review.

5

Distinct GAGE and MAGE-A expression during early human development indicate specific roles in lineage differentiation.

Gjerstorff MF, Harkness L, Kassem M, Frandsen U, Nielsen O, Lutterodt M, Møllgård K, Ditzel HJ. Gjerstorff MF, et al. Hum Reprod. 2008 Oct;23(10):2194-201. doi: 10.1093/humrep/den262. Epub 2008 Jul 8. Hum Reprod. 2008. PMID: 18611917

6

Epigenetic modulation of cancer-germline antigen gene expression in tumorigenic human mesenchymal stem cells: implications for cancer therapy.

Gjerstorff M, Burns JS, Nielsen O, Kassem M, Ditzel H. Gjerstorff M, et al. Am J Pathol. 2009 Jul;175(1):314-23. doi: 10.2353/ajpath.2009.080893. Epub 2009 Jun 4. Am J Pathol. 2009. PMID: 19498007 Free PMC article.

7

Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.

Gjerstorff MF, Burns J, Ditzel HJ. Gjerstorff MF, et al. Expert Opin Biol Ther. 2010 Jul;10(7):1061-75. doi: 10.1517/14712598.2010.485188. Expert Opin Biol Ther. 2010. PMID: 20420535 Review.

8

Expression, purification and characterization of the cancer-germline antigen GAGE12I: a candidate for cancer immunotherapy.

Gjerstorff MF, Besir H, Larsen MR, Ditzel HJ. Gjerstorff MF, et al. Protein Expr Purif. 2010 Oct;73(2):217-22. doi: 10.1016/j.pep.2010.05.010. Epub 2010 May 27. Protein Expr Purif. 2010. PMID: 20546897

9

GAGE cancer-germline antigens are recruited to the nuclear envelope by germ cell-less (GCL).

Gjerstorff MF, Rösner HI, Pedersen CB, Greve KB, Schmidt S, Wilson KL, Mollenhauer J, Besir H, Poulsen FM, Møllegaard NE, Ditzel HJ. Gjerstorff MF, et al. PLoS One. 2012;7(9):e45819. doi: 10.1371/journal.pone.0045819. Epub 2012 Sep 20. PLoS One. 2012. PMID: 23029259 Free PMC article.

10

Limited SP17 expression within tumors diminishes its therapeutic potential.

Gjerstorff MF, Ditzel HJ. Gjerstorff MF, et al. Tissue Antigens. 2012 Dec;80(6):523-7. doi: 10.1111/tan.12015. Tissue Antigens. 2012. PMID: 23137323

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters